A detailed history of Gryphon Financial Partners LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Gryphon Financial Partners LLC holds 2,007 shares of DGX stock, worth $275,139. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,007
Previous 2,013 0.3%
Holding current value
$275,139
Previous $275,000 -0.0%
% of portfolio
0.04%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$137.09 - $137.09 $822 - $822
-6 Reduced 0.3%
2,007 $275,000
Q2 2024

Aug 07, 2024

BUY
$125.91 - $144.34 $4,658 - $5,340
37 Added 1.87%
2,013 $275,000
Q1 2024

May 01, 2024

SELL
$123.78 - $142.11 $35,153 - $40,359
-284 Reduced 12.57%
1,976 $263,000
Q4 2023

Feb 06, 2024

BUY
$120.62 - $141.12 $26,898 - $31,469
223 Added 10.95%
2,260 $311,000
Q3 2023

Nov 07, 2023

SELL
$121.86 - $144.92 $22,544 - $26,810
-185 Reduced 8.33%
2,037 $248,000
Q2 2023

Aug 08, 2023

BUY
$130.56 - $146.84 $6,136 - $6,901
47 Added 2.16%
2,222 $312,000
Q1 2023

May 03, 2023

BUY
$131.53 - $155.76 $8,154 - $9,657
62 Added 2.93%
2,175 $307,000
Q4 2022

Feb 08, 2023

SELL
$123.31 - $157.26 $2,342 - $2,987
-19 Reduced 0.89%
2,113 $330,000
Q3 2022

Nov 14, 2022

SELL
$121.77 - $141.1 $69,287 - $80,285
-569 Reduced 21.07%
2,132 $262,000
Q2 2022

Jul 28, 2022

SELL
$127.07 - $145.39 $59,595 - $68,187
-469 Reduced 14.79%
2,701 $359,000
Q1 2022

May 05, 2022

SELL
$129.09 - $164.35 $300,521 - $382,606
-2,328 Reduced 42.34%
3,170 $433,000
Q4 2021

Feb 01, 2022

BUY
$140.36 - $173.01 $467,118 - $575,777
3,328 Added 153.36%
5,498 $951,000
Q3 2021

Nov 12, 2021

BUY
$132.95 - $158.0 $288,501 - $342,860
2,170 New
2,170 $315,000
Q3 2018

Nov 06, 2018

SELL
$105.42 - $114.99 $6,325 - $6,899
-60 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$90.86 - $100.24 $5,451 - $6,014
60
60 $6,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Gryphon Financial Partners LLC Portfolio

Follow Gryphon Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gryphon Financial Partners LLC with notifications on news.